小说小册子 修改原生前部中枢的小册子用于跨导管中枢更换
Parth Parikh1, Joseph Kassab1, Joshua Cohen1
1Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
JACC. Case reports
|October 3, 2024
概括
在环化中植入过导管可以导致左心室外流通道阻塞 (LVOTO). 这项研究展示了一种新的电外科技术,用于防止在膜内心膜手术过程中LVOTO.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 医疗器械技术 医疗器械技术
背景情况:
- 中心环状化 (MAC) 对门更换手术构成了挑战.
- 中心植入带有左心室外流通道阻塞 (LVOTO) 的风险.
研究的目的:
- 描述一项新技术在人体上首次应用,以防止LVOTO在跨导管中心膜手术过程中发生.
- 评估用于预防LVOTO的电术引导的小册子穿孔的安全性和可行性.
主要方法:
- 皮肤外电手术指导穿孔前额头门的说明书.
- 穿孔的传单的气球扩张.
- 随后进行过导管植入.
- 首次在人类身上进行病例演示.
主要成果:
- 成功执行了电术引导的穿孔和气球扩张技术.
- 在没有显著的LVOTO的情况下成功植入过导管.
- 展示一种可行的方法来减轻MAC中的LVOTO风险.
结论:
- 皮肤外电手术指导的前额叶片穿孔和扩张是一种可行的策略,可以防止在门中门手术期间LVOTO.
- 这种技术代表了在管理MAC患者复杂的门干预方面取得的重大进展.
相关概念视频
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


